...
首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >Remarkably high prevalence of fts I gene mutations in Haemophilus influenzae isolates from upper respiratory tract infections in children of the Sapporo district, Japan.
【24h】

Remarkably high prevalence of fts I gene mutations in Haemophilus influenzae isolates from upper respiratory tract infections in children of the Sapporo district, Japan.

机译:在日本札幌地区的儿童中,流感嗜血杆菌分离株的fts I基因突变患上呼吸道感染的患病率极高。

获取原文
获取原文并翻译 | 示例

摘要

Recently, the frequency of isolation of beta-lactamase-negative ampicillin resistant (BLNAR) strains of Haemophilus influenzae in Japanese children has been increasing rapidly. Drug resistance in BLNAR strains is associated with mutations of the fts I gene, which encodes penicillin-binding protein 3. In the otolaryngological field, only a few reports have been available concerning fts I gene mutations in BLNAR. We investigated the prevalence of fts I gene mutations, by polymerase chain reaction (PCR) genotyping, in H. influenzae isolates from the upper respiratory tracts of children in the Sapporo district, Japan. When the isolates were classified according to PCR genotyping, 34 (44.2%) of 77 isolates were beta-lactamase-negative ampicillin-sensitive (g-BLNAS), 8 (10.4%) were g-low-BLNAR, 30 (39.0%) were g-high-BLNAR, 2 (2.6%) were beta-lactamase-positive ampicillin-resistant (g-BLPAR), and 3 (3.9%) were beta-lactamase-positive ampicillin/clavulanic acid-resistant (g-high-BLPACR). Mutations in the fts I gene were generally parallel to ampicillin susceptibility, and were frequently observed in children who were 7 years or younger. Of the beta-lactams tested, cefditoren showed the strongest inhibition of H. influenzae isolates, and it inhibited g-BLNAR and g-BLPACR. This study revealed a remarkably high prevalence of fts I gene mutations (g-BLNAR and g-BLPACR) in our district. Furthermore, a regional difference in the prevalence of fts I gene mutations was observed even at the district level.
机译:最近,日本儿童流感嗜血杆菌的β-内酰胺酶阴性氨苄青霉素抗性(BLNAR)菌株的分离频率迅速增加。 BLNAR菌株中的耐药性与fts I基因的突变有关,该基因编码青霉素结合蛋白3。在耳鼻喉科学领域,关于BLNAR中fts I基因突变的报道很少。我们通过聚合酶链反应(PCR)基因分型,调查了日本札幌地区儿童上呼吸道的流感嗜血杆菌分离株中fts I基因突变的患病率。根据PCR基因分型对菌株进行分类时,77株菌株中有34株(44.2%)是β-内酰胺酶阴性的氨苄青霉素敏感性(g-BLNAS),8株(10.4%)是g-low-BLNAR,30株(39.0%)分别为g-high-BLNAR,2(2.6%)为抗β-内酰胺酶阳性的氨苄青霉素(g-BLPAR)和3(3.9%)为β-内酰胺酶阳性的氨苄青霉素/克拉维酸(g-high- BLPACR)。 fts I基因的突变通常与氨苄西林易感性平行,并且经常在7岁以下的儿童中观察到。在测试的β-内酰胺中,头孢托仑对流感嗜血杆菌分离株的抑制作用最强,并且抑制g-BLNAR和g-BLPACR。这项研究表明,在我们地区,fts I基因突变(g-BLNAR和g-BLPACR)的患病率非常高。此外,即使在地区一级,也发现了fts I基因突变发生率的区域差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号